• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用金属螯合剂(包括香豆素衍生物)靶向阿尔茨海默病中的生物金属。

Targeting Biometals in Alzheimer's Disease with Metal Chelating Agents Including Coumarin Derivatives.

机构信息

Department of Biochemistry, Institute of Chemical Sciences, Faculty of Science, P. J. Šafárik University in Košice, Moyzesova 11, 040 01, Kosice, Slovak Republic.

Department of Organic Chemistry, Institute of Chemical Sciences, Faculty of Science, P. J. Šafárik University in Košice, Moyzesova 11, 040 01, Kosice, Slovak Republic.

出版信息

CNS Drugs. 2024 Jul;38(7):507-532. doi: 10.1007/s40263-024-01093-0. Epub 2024 Jun 3.

DOI:10.1007/s40263-024-01093-0
PMID:38829443
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11182807/
Abstract

Numerous physiological processes happening in the human body, including cerebral development and function, require the participation of biometal ions such as iron, copper, and zinc. Their dyshomeostasis may, however, contribute to the onset of Alzheimer's disease (AD) and potentially other neurodegenerative diseases. Chelation of biometal ions is therefore a therapeutic strategy against AD. This review provides a survey of natural and synthetic chelating agents that are or could potentially be used to target the metal hypothesis of AD. Since metal dyshomeostasis is not the only pathological aspect of AD, and the nature of this disorder is very complex and multifactiorial, the most efficient therapeutics should target as many neurotoxic factors as possible. Various coumarin derivatives match this description and apart from being able to chelate metal ions, they exhibit the capacity to inhibit cholinesterases (ChEs) and monoamine oxidase B (MAO-B) while also possessing antioxidant, anti-inflammatory, and numerous other beneficial effects. Compounds based on the coumarin scaffold therefore represent a desirable class of anti-AD therapeutics.

摘要

人体中有许多生理过程,包括大脑发育和功能,都需要生物金属离子(如铁、铜和锌)的参与。然而,它们的动态平衡失调可能导致阿尔茨海默病(AD)的发生,并可能导致其他神经退行性疾病。因此,螯合生物金属离子是一种针对 AD 的治疗策略。本综述提供了对天然和合成螯合剂的调查,这些螯合剂或有可能被用于针对 AD 的金属假说。由于金属动态平衡失调不是 AD 的唯一病理方面,而且这种疾病的性质非常复杂和多因素,因此最有效的治疗方法应该针对尽可能多的神经毒性因素。各种香豆素衍生物符合这一描述,除了能够螯合金属离子外,它们还具有抑制胆碱酯酶(ChE)和单胺氧化酶 B(MAO-B)的能力,同时还具有抗氧化、抗炎和许多其他有益作用。因此,基于香豆素支架的化合物代表了一类有前途的抗 AD 治疗药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53fa/11182807/75e94a9292ce/40263_2024_1093_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53fa/11182807/c82946f2ecf3/40263_2024_1093_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53fa/11182807/61d27545a88a/40263_2024_1093_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53fa/11182807/857947730a98/40263_2024_1093_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53fa/11182807/9dfb1f595826/40263_2024_1093_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53fa/11182807/a67130ee5641/40263_2024_1093_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53fa/11182807/54a4750dc1f2/40263_2024_1093_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53fa/11182807/e979336146d1/40263_2024_1093_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53fa/11182807/98246e2c3b8a/40263_2024_1093_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53fa/11182807/b71538309fdc/40263_2024_1093_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53fa/11182807/31f6ecb09619/40263_2024_1093_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53fa/11182807/956ee7cfab4c/40263_2024_1093_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53fa/11182807/fac55fdac68f/40263_2024_1093_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53fa/11182807/75e94a9292ce/40263_2024_1093_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53fa/11182807/c82946f2ecf3/40263_2024_1093_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53fa/11182807/61d27545a88a/40263_2024_1093_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53fa/11182807/857947730a98/40263_2024_1093_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53fa/11182807/9dfb1f595826/40263_2024_1093_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53fa/11182807/a67130ee5641/40263_2024_1093_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53fa/11182807/54a4750dc1f2/40263_2024_1093_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53fa/11182807/e979336146d1/40263_2024_1093_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53fa/11182807/98246e2c3b8a/40263_2024_1093_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53fa/11182807/b71538309fdc/40263_2024_1093_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53fa/11182807/31f6ecb09619/40263_2024_1093_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53fa/11182807/956ee7cfab4c/40263_2024_1093_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53fa/11182807/fac55fdac68f/40263_2024_1093_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53fa/11182807/75e94a9292ce/40263_2024_1093_Fig13_HTML.jpg

相似文献

1
Targeting Biometals in Alzheimer's Disease with Metal Chelating Agents Including Coumarin Derivatives.用金属螯合剂(包括香豆素衍生物)靶向阿尔茨海默病中的生物金属。
CNS Drugs. 2024 Jul;38(7):507-532. doi: 10.1007/s40263-024-01093-0. Epub 2024 Jun 3.
2
Metallobiology and therapeutic chelation of biometals (copper, zinc and iron) in Alzheimer's disease: Limitations, and current and future perspectives.金属生物学与生物金属(铜、锌和铁)在阿尔茨海默病中的治疗螯合作用:局限性,以及当前和未来的展望。
J Trace Elem Med Biol. 2021 Sep;67:126779. doi: 10.1016/j.jtemb.2021.126779. Epub 2021 May 15.
3
Management of oxidative stress and other pathologies in Alzheimer's disease.阿尔茨海默病中氧化应激和其他病理的管理。
Arch Toxicol. 2019 Sep;93(9):2491-2513. doi: 10.1007/s00204-019-02538-y. Epub 2019 Aug 22.
4
Multifunctional coumarin derivatives: monoamine oxidase B (MAO-B) inhibition, anti-β-amyloid (Aβ) aggregation and metal chelation properties against Alzheimer's disease.多功能香豆素衍生物:对阿尔茨海默病的单胺氧化酶B(MAO-B)抑制、抗β-淀粉样蛋白(Aβ)聚集及金属螯合特性
Bioorg Med Chem Lett. 2015 Feb 1;25(3):508-13. doi: 10.1016/j.bmcl.2014.12.034. Epub 2014 Dec 19.
5
Rivastigmine-Benzimidazole Hybrids as Promising Multitarget Metal-Modulating Compounds for Potential Treatment of Neurodegenerative Diseases.利伐斯的明-苯并咪唑杂合体作为有前途的多靶点金属调节化合物,用于潜在治疗神经退行性疾病。
Int J Mol Sci. 2023 May 5;24(9):8312. doi: 10.3390/ijms24098312.
6
Recent Multi-target Approaches on the Development of Anti- Alzheimer's Agents Integrating Metal Chelation Activity.近期整合金属螯合活性的抗阿尔茨海默病药物开发中的多靶点方法
Curr Med Chem. 2021;28(35):7247-7277. doi: 10.2174/0929867328666210218183032.
7
Site-activated multi target iron chelators with acetylcholinesterase (AChE) and monoamine oxidase (MAO) inhibitory activities for Alzheimer's disease therapy.具有乙酰胆碱酯酶(AChE)和单胺氧化酶(MAO)抑制活性的位点激活多靶铁螯合剂用于治疗阿尔茨海默病。
J Neural Transm (Vienna). 2022 Jun;129(5-6):715-721. doi: 10.1007/s00702-022-02462-z. Epub 2022 Feb 21.
8
Pyridoxine-resveratrol hybrids Mannich base derivatives as novel dual inhibitors of AChE and MAO-B with antioxidant and metal-chelating properties for the treatment of Alzheimer's disease.吡哆醇-白藜芦醇杂合曼尼希碱衍生物作为新型乙酰胆碱酯酶和单胺氧化酶-B双重抑制剂,具有抗氧化和金属螯合特性,用于治疗阿尔茨海默病。
Bioorg Chem. 2017 Apr;71:305-314. doi: 10.1016/j.bioorg.2017.02.016. Epub 2017 Feb 28.
9
Dual-target anti-Alzheimer's disease agents with both iron ion chelating and monoamine oxidase-B inhibitory activity.具有铁离子螯合和单胺氧化酶-B 抑制活性的双重靶向抗阿尔茨海默病药物。
J Enzyme Inhib Med Chem. 2019 Dec;34(1):1489-1497. doi: 10.1080/14756366.2019.1634703.
10
New 4-N-phenylaminoquinoline derivatives as antioxidant, metal chelating and cholinesterase inhibitors for Alzheimer's disease.新型 4-N-苯基氨基喹啉衍生物兼具抗氧化、金属螯合和乙酰胆碱酯酶抑制活性,可用于治疗阿尔茨海默病。
Bioorg Chem. 2019 Dec;93:103328. doi: 10.1016/j.bioorg.2019.103328. Epub 2019 Sep 28.

引用本文的文献

1
Mitochondrial dysfunction in the regulation of aging and aging-related diseases.线粒体功能障碍在衰老及衰老相关疾病调控中的作用
Cell Commun Signal. 2025 Jun 19;23(1):290. doi: 10.1186/s12964-025-02308-7.
2
Homeostasis and metabolism of iron and other metal ions in neurodegenerative diseases.神经退行性疾病中铁及其他金属离子的稳态与代谢
Signal Transduct Target Ther. 2025 Feb 3;10(1):31. doi: 10.1038/s41392-024-02071-0.
3
Recent advancements in the therapeutic approaches for Alzheimer's disease treatment: current and future perspective.

本文引用的文献

1
Iron and Targeted Iron Therapy in Alzheimer's Disease.阿尔茨海默病中的铁和靶向铁治疗。
Int J Mol Sci. 2023 Nov 15;24(22):16353. doi: 10.3390/ijms242216353.
2
A coumarin-based multifunctional chemosensor for Cu/Al as an AD theranostic agent: Synthesis, X-ray single crystal analysis and activity study.基于香豆素的多功能铜/铝化学传感器作为 AD 治疗剂:合成、X 射线单晶分析及活性研究。
Anal Chim Acta. 2023 Oct 23;1279:341818. doi: 10.1016/j.aca.2023.341818. Epub 2023 Sep 12.
3
Iron chelators as a therapeutic option for Alzheimer's disease-A mini-review.
阿尔茨海默病治疗方法的最新进展:现状与未来展望。
RSC Med Chem. 2024 Dec 6;16(2):652-693. doi: 10.1039/d4md00630e. eCollection 2025 Feb 19.
4
Neuroprotective Potential of Indole-Based Compounds: A Biochemical Study on Antioxidant Properties and Amyloid Disaggregation in Neuroblastoma Cells.基于吲哚的化合物的神经保护潜力:对神经母细胞瘤细胞抗氧化特性和淀粉样蛋白解聚的生化研究
Antioxidants (Basel). 2024 Dec 23;13(12):1585. doi: 10.3390/antiox13121585.
5
X-ray Fluorescence Microscopy to Develop Elemental Classifiers and Investigate Elemental Signatures in BALB/c Mouse Intestine a Week after Exposure to 8 Gy of Gamma Rays.X 射线荧光显微镜用于开发元素分类器,并研究 BALB/c 小鼠在暴露于 8Gy 伽马射线一周后肠道中的元素特征。
Int J Mol Sci. 2024 Sep 24;25(19):10256. doi: 10.3390/ijms251910256.
6
Copper ions: The invisible killer of cardiovascular disease (Review).铜离子:心血管疾病的隐形杀手(综述)。
Mol Med Rep. 2024 Nov;30(5). doi: 10.3892/mmr.2024.13334. Epub 2024 Sep 20.
铁螯合剂作为阿尔茨海默病的一种治疗选择——一篇综述
Front Aging. 2023 Aug 2;4:1234958. doi: 10.3389/fragi.2023.1234958. eCollection 2023.
4
Sulfur-bridging the gap: investigating the electrochemistry of novel copper chelating agents for Alzheimer's disease applications.硫桥连接缺口:研究新型铜螯合剂在阿尔茨海默病应用中的电化学性质。
J Biol Inorg Chem. 2023 Oct;28(7):643-653. doi: 10.1007/s00775-023-02013-1. Epub 2023 Aug 18.
5
Chelator PBT2 Forms a Ternary Cu Complex with β-Amyloid That Has High Stability but Low Specificity.螯合剂 PBT2 与β-淀粉样蛋白形成具有高稳定性但低特异性的三元 Cu 配合物。
Int J Mol Sci. 2023 May 25;24(11):9267. doi: 10.3390/ijms24119267.
6
Metals in Alzheimer's Disease.阿尔茨海默病中的金属
Biomedicines. 2023 Apr 12;11(4):1161. doi: 10.3390/biomedicines11041161.
7
Exploring the Multitarget Activity of Wedelolactone against Alzheimer's Disease: Insights from Study.探索水飞蓟宾对阿尔茨海默病的多靶点活性:来自[研究名称]的见解 。 (你原文中“from Study”这里“Study”前缺少具体内容,我按原样翻译了,你可补充完整后再让我翻译)
ACS Omega. 2023 Apr 18;8(17):15031-15040. doi: 10.1021/acsomega.2c08014. eCollection 2023 May 2.
8
Design, synthesis, and evaluation of 2,2'-bipyridyl derivatives as bifunctional agents against Alzheimer's disease.设计、合成及评价 2,2'-联吡啶衍生物作为治疗阿尔茨海默病的双功能试剂。
Mol Divers. 2024 Jun;28(3):1225-1238. doi: 10.1007/s11030-023-10651-5. Epub 2023 Apr 29.
9
Chelating the valley of death: Deferoxamine's path from bench to wound clinic.螯合死亡谷:去铁胺从实验室到伤口诊所的历程。
Front Med (Lausanne). 2023 Feb 15;10:1015711. doi: 10.3389/fmed.2023.1015711. eCollection 2023.
10
New thiourea and benzamide derivatives of 2-aminothiazole as multi-target agents against Alzheimer's disease: Design, synthesis, and biological evaluation.新型 2-氨基噻唑硫脲和苯甲酰胺衍生物作为阿尔茨海默病多靶点药物的设计、合成与生物评价。
Bioorg Chem. 2023 Feb;131:106322. doi: 10.1016/j.bioorg.2022.106322. Epub 2022 Dec 14.